drugset / Trial / NCT00496561

Effect of Specific Immunotherapy to Dust Mites in Children With Asthma

NCT00496561 ↗

Phase 4 Unknown 80 enrolled Medical University of Lodz
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to assess the effect of specific immunotherapy (SIT) to dust mites on clinical symptoms, reliever drugs usage, inhaled glucocorticosteroid usage, quality of life, lung function, chosen markers of inflammation, induction of regulatory lymphocytes, bronchial hyperreactivity with methacholine, and presence and type of allergy after two years of SIT in children with asthma.

Timeline

Start
2006-08
Primary completion
2013-11
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator House Dust Mites Unknown — Subcutaneous

Indications